Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
FINDEX Inc. ( (JP:3649) ) has shared an announcement.
FINDEX Inc. reported preliminary implementation results for its suite of medical and government IT products as of December 31, 2025, showing steady expansion across hospitals, clinics and local governments. Core products such as the Claio data management software, DocuMaker document management system and REMORA electronic medical record platform all recorded net user gains, while the GAP/GAP-screener gaze analyzing perimeter reached 213 shipped units after a notable increase since the previous update. The figures indicate continued penetration of FINDEX’s solutions in university and general hospitals, growth in clinic deployments, and incremental uptake of its DocuMaker Office offering among local governments, underscoring the company’s strengthening presence in Japan’s healthcare and public-sector digitalization market.
The most recent analyst rating on (JP:3649) stock is a Buy with a Yen1156.00 price target. To see the full list of analyst forecasts on FINDEX Inc. stock, see the JP:3649 Stock Forecast page.
More about FINDEX Inc.
FINDEX Inc. is a Japan-based provider of medical and public-sector IT solutions, specializing in software for hospitals, clinics and local governments. Its product lineup includes electronic medical records, document and data management systems, perinatal information platforms, cloud services for medical institutions, and document/public document management tools for government and hospital use.
Average Trading Volume: 59,925
Technical Sentiment Signal: Buy
Current Market Cap: Yen24.46B
See more data about 3649 stock on TipRanks’ Stock Analysis page.